Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Still´s Disease”

4 trials

Showing 4 of 4 results

Testing effectiveness (Phase 2)Ended earlyNCT02204293
What this trial is testing

Canakinumab for Treatment of Adult-onset Still's Disease

Who this might be right for
Adult-Onset Still´s Disease
Charite University, Berlin, Germany 36
Testing effectiveness (Phase 2)Looking for participantsNCT07203001
What this trial is testing

A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease

Who this might be right for
Still´s Disease
Novartis Pharmaceuticals 20
Large-scale testing (Phase 3)Study completedNCT06497491
What this trial is testing

An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Still's Disease

Who this might be right for
Still's Disease Adult Onset
AO GENERIUM 118
Not applicableNot Yet RecruitingNCT07191444
What this trial is testing

Firsekibart Versus Anakinra in Adult-Onset Still's Disease

Who this might be right for
Still's Disease, Adult-Onset
Ruijin Hospital 20

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation